🕵️ OS Therapies Inc ($OSTX)
SEC insider & ownership activity, last 12 months · CIK 1795091 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. Thomas A. Satterfield, JR. added 5.9% → 9.4%; Shalom Auerbach trimmed 9.9% → 8.5%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ayala Pharmaceuticals, Inc. | 10.0% | 13G | Apr 16, 2025 | filing ↗ | |
| Thomas A. Satterfield, JR. | 9.4% | 13G | Aug 13, 2025 | filing ↗ | |
| Shalom Auerbach | 8.5% | 13D | Jul 29, 2025 | filing ↗ | |
| Einodmil LLC | 8.4% | 13D | Jul 29, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Sep 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Sep 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Sep 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 21, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 6, 2026 | filing ↗ |
| New financial obligation (2.03) | Aug 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 31, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 31, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jul 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 30, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 30, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 30, 2026 | filing ↗ |
| Other events (8.01) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |